Sign in
Back
Secukinumab Provides Rapid Relief From Itching and Pain in Patients with Moderate-to-Severe Psoriasis: Patient Symptom Diary Data from Two Phase 3, Randomized, Placebo-controlled Clinical Trials
Journal article   Open access  Peer reviewed

Secukinumab Provides Rapid Relief From Itching and Pain in Patients with Moderate-to-Severe Psoriasis: Patient Symptom Diary Data from Two Phase 3, Randomized, Placebo-controlled Clinical Trials

Gil Yosipovitch, Jennifer Soung, Jonathan Weiss, Elisa Muscianisi, Xiangyi Meng, Isabelle Gilloteau and Boni E Elewski
Acta dermato-venereologica, Vol.99(9), pp.820-821
2019-07-01
DOI: https://doi.org/10.2340/00015555-3195
PMID: 31017248

Abstract

Antibodies, Monoclonal, Humanized - therapeutic use Clinical Trials, Phase III as Topic Dermatologic Agents - therapeutic use Humans Pain - diagnosis Pain - drug therapy Pain - psychology Pruritus - diagnosis Pruritus - drug therapy Pruritus - psychology Psoriasis - diagnosis Psoriasis - drug therapy Psoriasis - psychology Quality of Life Randomized Controlled Trials as Topic Remission Induction Severity of Illness Index Time Factors Treatment Outcome
url
https://doi.org/10.2340/00015555-3195View
Published (Version of record) Open

Metrics

4 Record Views
11 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.106 Rheumatology
1.106.737 Psoriasis
Web Of Science research areas
Dermatology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details